Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People coinfected with HIV and hepatitis C have rising rates of liver cancer while their rates of other liver health events are falling.
However, NAFLD is by far the most common cause of cirrhosis among all ethnic groups in this country.
It began with honesty, and before she knew it, Stella Armstrong was helping others with hepatitis C
Most diagnoses are among baby boomers.
The new once-daily, single-tablet, pangenotypic hepatitis C treatment has the potential to shake things up in the United States and abroad.
Hepatitis C virus cure rates among those who have received a liver transplant are very good.
The move is intended to combat rising hepatitis C infection and incarceration rates linked to the region’s ongoing heroin epidemic.
Mass imprisonment of drug users worldwide and insufficient harm reduction propel the spread of HIV, hepatitis B and C and tuberculosis.
An op-ed about viral hepatitis funding compared to funding for Zika virus.
Local advocacy groups say misinformation and stigma have prevented the majority of people who need the lifesaving drug from accessing it.
An interview with Dr. Mojca Matičič, Head of the National Viral Hepatitis Expert Group in Slovenia.
The cost per hepatitis C cure liked with Harvoni is lower than with regimens including the first generation of direct-acting antivirals.
It’s been more than a year since local health officials sought state help to combat the region’s growing hepatitis C and HIV threats.
This HEP story shows the amazing changes that one ordinary but determined woman with hepatitis C can bring about.
Actions include expanding access to buprenorphine treatment and launching more than a dozen new studies on drug abuse and chronic pain.